Arteriocyte is now a part of Isto Biologics.




Thompson Street Capital PartnersTSCP

Thompson Street Capital Partners is a St. Louis-based private equity firm with a focus on investing in growing, profitable middle-market companies headquartered in North America. The firm partners with high-quality management teams to support growth – both organically and via acquisitions.  Thompson Street manages more than $1.5 billion in equity across four funds and is currently investing out of its $640 million TSCP Fund IV.

A Projection of Growth

“We believe our data-supported orthobiologic products will provide improvements in clinical outcomes and quality of life for patients, while offering payers and providers lower-priced alternatives that work better than traditional orthopedic devices. Our business model processes are scalable and cost effective, allowing ISTO to develop a sustainable competitive advantage to aggressively increase shareholder value.”

George Dunbar, ISTO President and Chief Executive Officer

To top